San Diego · Pre-Seed–Seed · 4 people tracked
Find your way into Illumina Accelerator
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jeremy Loh to introduce you to Frances H. Arnold
You →Jeremy · together at JBEI →Frances
Ask Jamie Chen to introduce you to Ankur Dhingra
You →Jamie · together at Summit Therapeutics →Ankur
Ask Sam Okafor to introduce you to Sue Siegel
You →Sam · together at Obvious Ventures →Sue
- Gary Guthart40 people can intro you
Sign up to find every way you can get introduced to Illumina Accelerator
- Your email: who you already know at Illumina Accelerator, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Illumina Accelerator team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Illumina for Startups aims to accelerate innovation in the genomics entrepreneurial community by partnering with venture investors and entrepreneurs to create, launch, and grow genomics startups. It advances breakthrough genomics applications spanning therapeutics, diagnostics, agriculture, synthetic biology, software, and direct-to-consumer uses. The program offers grants that let entrepreneurs run proof-of-concept next-generation sequencing experiments at selected Illumina sites, providing access to MiSeq, NextSeq, and NovaSeq systems plus Illumina reagents, technical advice, experiment-planning meetings with scientists, and connections to subject-matter experts. The former Illumina Accelerator, which operated in the San Francisco Bay Area since 2014 and Cambridge, UK since 2020, joined Illumina Ventures in 2023 and relaunched as Illumina Ventures Labs.
Source: firm website, verified Sep 27, 2026.
Team · 4 people
from curatedWhat they invest in
from 5 of 12 portfolio companiesAI & Machine Learning ×3Biotech ×3Digital Health ×3Healthtech ×3Deep Tech ×2Direct to Consumer ×1FemTech ×1Marketing Tech ×1
HQs:United States×2United Kingdom×1
Portfolio companies · 12 tracked
alumni founders can tell you what the program is really likeBy year:2026 · 22021 · 13 dated
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsFormation Venture Engineering
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.
BiotechDigital HealthMedical DevicesSan Carlos, US
Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in
Co-investorsBerkeley Angel NetworkBlue Bear Ventures
Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBeast Ventures
Juno is a research platform that runs unscripted, asynchronous qualitative interviews with real people and analyzes the responses at scale, connecting themes to source quotes.
AI & Machine LearningMarketing TechSaaS
Michelle Gilmore(CEO)
Co-investorsBlackbird VenturesFlying Fox VenturesAda VenturesArtesianEntrepreneur First
Juno offers an at-home vaginal microbiome test paired with results, treatment plans, and support from OB-GYNs and researchers, aimed at helping people manage vaginal symptoms and infections.
Digital HealthDirect to ConsumerFemTechHealthtechLondon, GB
Hana Janebdar(CEO)inLeighton Turner(CTO)in
Co-investorsAI SeedEntrepreneur FirstAda VenturesArtesian
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
About Us.HtmlContact Us.HtmlCustomer Engagement Center.HtmlDoing Business With Illumina.HtmlNews Center.HtmlOverviewSkip to content
Portfolio news
latest coverage across their companiesJuno Bio · finsmes.com · Jul 17, 2026
Frequently asked questions
- How many investments has Illumina Accelerator made?
- Illumina Accelerator has 12 tracked investments, including 2 dated in the last 24 months.
- What stage does Illumina Accelerator invest at?
- Illumina Accelerator invests at the Pre-Seed, Seed stages.
- What sectors does Illumina Accelerator focus on?
- Illumina Accelerator focuses on AgTech, Biotech, Deep Tech, Digital Health, Healthtech.
- Where is Illumina Accelerator located?
- Illumina Accelerator is headquartered in San Diego, US.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.













.jpeg)







